E71.31 - Disorders of fatty-acid oxidation
- Applicable to Disorders of fatty-acid oxidation
- The 2025 edition of ICD10-CM E71.31 became effective on October 1, 2024.
- This is the American ICD10-CM version of E71.31 - other international versions of ICD10 E71.31 may differ.
- E71.31 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- E71.31 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- E71.31 - Disorders of fatty-acid oxidation
- E71.31 - Disorders of fatty-acid oxidation
- E71.310 - Long chain/very long chain acyl CoA dehydrogenase deficiency
- E71.311 - Medium chain acyl CoA dehydrogenase deficiency
- E71.312 - Short chain acyl CoA dehydrogenase deficiency
- E71.313 - Glutaric aciduria type II
- E71.314 - Muscle carnitine palmitoyltransferase deficiency
- E71.318 - Other disorders of fatty-acid oxidation
The following codes above E71.31 contain annotation back-references that may be applicable to E71.31:
Chapter: E00-E89 Endocrine, nutritional and metabolic diseases
Section: E70-E88 Metabolic disorders
Category: E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com